A randomised, double blind, placebo-controlled, multicentre study in asymptomatic HIV infected patients to investigate pharmacodynamics, pharmacokinetics, safety and toleration of UK-453,061

| Country :
| organs :
| Specialty :

Extract

Investigate the effects of 7-day monotherapy of UK-453,061 on viral load response in asymptomatic HIV infected patients and to assess the dose-response relationship. Assess the pharmacokinetics, safety and tolerability of UK-453,061 in asymptomatic HIV infected patients.

Kusajili – Clinical trials directory

A randomised, double blind, placebo-controlled, multicentre study in asymptomatic HIV infected patients to investigate pharmacodynamics, pharmacokinetics, safety and toleration of UK-453,061

Extract

Inclusion criteria

Links